Pendarvis Christiane

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pendarvis Christiane's trades of Hims & Hers Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
16.92
Quantity 42,806
Value US$2,229,505
Transaction date
Sale
Price
151.58
Quantity 4,197 +39.7%
Value US$1,017,193
Transaction date
Proposed sale
Price
441.86
Quantity 73,093
Value US$110,654
Transaction date
Sale
Price
15.15
Quantity 7,000 -22.6%
Value US$106,064
Transaction date
Proposed sale
Price
15.15
Quantity 7,000
Value US$106,067
Transaction date
Sale
Price
12.33
Quantity 4,000 -26.3%
Value US$49,320
Transaction date
Proposed sale
Price
12.33
Quantity 4,000
Value US$49,320
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2026-07-22
PrS Proposed sale
42,806
16.92
US$2,229,505 		42,806 16.92 US$2,229,505
2025-03-06 2025-03-05
S Sale
4,197 +39.7%
151.58
US$1,017,193 		4,197 +39.7% 151.58 US$1,017,193
2025-03-05 2025-03-05
PrS Proposed sale
73,093
441.86
US$110,654 		73,093 441.86 US$110,654
2024-08-28 2024-08-27
S Sale
7,000 -22.6%
15.15
US$106,064 		7,000 -22.6% 15.15 US$106,064
2024-08-27 2024-08-27
PrS Proposed sale
7,000
15.15
US$106,067 		7,000 15.15 US$106,067
2024-05-14 2024-05-13
S Sale
4,000 -26.3%
12.33
US$49,320 		4,000 -26.3% 12.33 US$49,320
2024-05-13 2024-05-13
PrS Proposed sale
4,000
12.33
US$49,320 		4,000 12.33 US$49,320